Israel Englander Terns Pharmaceuticals, Inc. Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.54 - $8.2 $152,998 - $276,340
33,700 Added 206.75%
50,000 $340,000
Q1 2024

May 15, 2024
SELL
$4.86 - $8.19 $163,782 - $276,003
-33,700 Reduced 67.4%
16,300 $106,000
Q4 2023

Feb 14, 2024
BUY
$3.37 - $6.86 $168,500 - $343,000
50,000 New
50,000 $324,000

Others Institutions Holding TERN

# of Institutions
132
Shares Held
63.4M
Call Options Held
413K
Put Options Held
106K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $314M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email